When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Espondiloartrite axial

Last reviewed: 17 Aug 2025
Last updated: 02 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • dorsalgia inflamatória
  • irite/uveíte
  • entesite
  • apresentação no final da adolescência e logo após os 20 anos
  • sexo masculino
  • história familiar positiva de espondilite anquilosante (EA)
Full details

Other diagnostic factors

  • fadiga
  • perturbação do sono
  • sensibilidade na articulação sacroilíaca
  • dispneia
  • perda de lordose lombar
  • comprometimento das articulações periféricas
  • cifose
  • psoríase
  • sintomas de doença inflamatória intestinal
Full details

Risk factors

  • HLA (antígeno leucocitário) B27
  • polimorfismos nos genes aminopeptidase 1 do retículo endoplasmático (ERAP1) e receptor de interleucina 23 (IL23R)
  • história familiar positiva de espondilite anquilosante (EA)
  • sexo masculino
Full details

Diagnostic investigations

1st investigations to order

  • radiografia pélvica
Full details

Investigations to consider

  • HLA (antígeno leucocitário) B27
  • RNM
  • radiografia da coluna cervical (lateral)
  • radiografia da coluna lombar (lateral)
  • radiografia da coluna torácica (lateral)
  • ultrassonografia
Full details

Treatment algorithm

ACUTE

adultos com dor e/ou rigidez

adultos sem dor e/ou rigidez

crianças

ONGOING

adultos com dor e/ou rigidez refratária a 2 anti-inflamatórios não esteroidais (AINEs) e medidas não farmacológicas

Contributors

Authors

Antoni Chan, MBChB, FRCP, PhD

Consultant

Rheumatology Department

Royal Berkshire NHS Foundation Trust

Reading

UK

Disclosures

AC has served on the advisory boards for MSD, Novartis, and Sanofi; contributed to educational events for Janssen, MSD, Novartis, Sanofi, and Celgene; been on the speaker bureau for Janssen, Pfizer, and Novartis; and received travel grants from AbbVie, UCB, Lilly, and Pfizer to attend educational conferences.

Sarah Sacks, MBBS, BSc

Specialist Registrar in Rheumatology

Stoke Mandeville Hospital

Aylesbury

UK

Disclosures

SS declares that she has no competing interests.

Acknowledgements

Dr Antoni Chan and Dr Sarah Sacks would like to gratefully acknowledge Dr Jessica Gunn, Dr Sarah Keidel, Dr Millicent Stone, Dr Raj Sengupta, Dr Athimalaipet V. Ramanan, and Dr Emma Pomeroy, the previous contributors to this topic. We would like to gratefully acknowledge the late Dr Andrew Keat, Consultant Physician and Rheumatologist at Northwick Park Hospital for his contribution to this topic as a peer reviewer.

Disclosures

JG, SK, RS, and AVR declare that they have no competing interests. MS is an author of several references cited in this topic. EP is an author of a reference cited in this topic.

Peer reviewers

Roger Sturrock, MD, FRCP

Professor of Rheumatology

Centre for Rheumatic Diseases

University Department of Medicine

Glasgow Royal Infirmary University Trust

Glasgow

UK

Disclosures

RS is an author of a reference cited in this topic.

Karl Gaffney, BCh, BAO (Hons), FRCPI, FRCP

Consultant

Norfolk and Norwich University Hospital

Norwich and the Cromer & District Hospital

Cromer

UK

利益声明

KG is an author of a reference cited in this topic.

Alexios G. Carayannopoulos, DO, MPH

Interventional Spine Physiatrist

Pain Medicine Specialist

Medical Director

Spine Center

Lahey Clinic

Burlington

MA

利益声明

AGC declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023 Jan;82(1):19-34.全文  摘要

Ward MM, Deodhar A, Gensler LS, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis andnonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2019 Oct;71(10):1599-613.全文  摘要

National Institute for Health and Care Excellence. Spondyloarthritis in over 16s: diagnosis and management. Jun 2017 [internet publication].全文

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Espondiloartrite axial images
  • 鉴别诊断

    • Osteoartrite
    • Hiperostose esquelética idiopática difusa (DISH)
    • Artrite psoriática
    更多 鉴别诊断
  • 指南

    • Consensus on targeted drug therapy for spondyloarthritis
    • Guideline for vaccinations in patients with rheumatic and musculoskeletal diseases
    更多 指南
  • 患者教育信息

    Espondiloartrite axial: quais são as opções de tratamento?

    Espondiloartrite axial: o que é?

    更多 患者教育信息
  • Videos

    Demonstração animada de aspiração e injeção no joelho

    Demonstração animada de aspiração e injeção do ombro

    更多 操作视频
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明